PIRS

Pieris Pharmaceuticals, Inc.

Latest period2024 - Q3Total superinvestors25

Top 10 Superinvestors by Shares Owned

This chart shows the top 10 superinvestors based on the number of shares they owned in 2024-Q2 and 2024-Q3. According to the most recent SEC 13F filing, 25 superinvestors own shares of Pieris Pharmaceuticals, Inc. (PIRS), although recent data may remain incomplete due to pending filings.

Quarter-over-Quarter Change (%)

This chart highlights the quarter-over-quarter change (%) in the number of superinvestors holding Pieris Pharmaceuticals, Inc. (PIRS), the total shares they held, and the total reported dollar value. It gives a clear view of whether there is ongoing momentum. The dotted lines at the top and bottom adjust longer bars to keep smaller data points visible for better comparison.

Superinvestors' Activity (%) Over the Last 4 Quarters

This chart shows superinvestors' activity with Pieris Pharmaceuticals, Inc. (PIRS) over the last four quarters, highlighting the percentage of investors who added, increased, decreased, held, or exited their positions, revealing shifts in sentiment over time.

Superinvestors' Past Actions

This chart displays superinvestors' past actions with Pieris Pharmaceuticals, Inc. (PIRS) over the last 10 years (40 quarters), helping to visualize the collective momentum and investment trends over time.

Superinvestors ownership

CurrentNew PositionIncreasedDecreasedExited
SuperinvestorPortfolio %Reported Value
Mark N. Lampert@Bvf Inc Il
Recent Activity
0.13%
$4.313M
257,626 shares@ 16.74 avg price
Stephen Scipione@Adar1 Capital Management, Llc
Recent Activity
New Position
0.4%
$2.398M
144,641 shares@ 16.59 avg price
Aryn Sands@Bml Capital Management, Llc
Recent Activity
New Position
0.42%
$698,515
42,130 shares@ 16.58 avg price
Weston Nichols@Lynx1 Capital Management Lp
Recent Activity
Decreased -13.93%
0.22%
$620,689
37,436 shares@ 16.59 avg price
Tiffany Michel@Renaissance Technologies Llc
Recent Activity
Increased 180.46%
0.01%
$533,395
32,171 shares@ 16.58 avg price
Mark R. Lilly@Cm Management, Llc
Recent Activity
New Position
0.3%
$373,050
22,500 shares@ 16.58 avg price
Steve R. Bailey@Frazier Life Sciences Management, L.p.
Recent Activity
New Position
0.02%
$266,869
15,942 shares@ 16.74 avg price
Spencer Fleming@Blackrock, Inc.
Recent Activity
New Position
0.01%
$214,512
12,938 shares@ 16.58 avg price
Laura Doherty@Geode Capital Management, Llc
Recent Activity
Increased 12.79%
0.01%
$200,614
11,981 shares@ 16.75 avg price
Michael Henry@Citadel Advisors Llc
Recent Activity
New Position
0.01%
$195,623
11,686 shares@ 16.74 avg price